Amy L. Parkhill, Ph.D. - Publications
Affiliations: | 2003 | University of Rochester, Rochester, NY |
Area:
PharmacologyYear | Citation | Score | |||
---|---|---|---|---|---|
2006 | Bidlack JM, Khimich M, Parkhill AL, Sumagin S, Sun B, Tipton CM. Opioid receptors and signaling on cells from the immune system. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 1: 260-9. PMID 18040803 DOI: 10.1007/S11481-006-9026-2 | 0.536 | |||
2006 | Wentland MP, VanAlstine M, Kucejko R, Lou R, Cohen DJ, Parkhill AL, Bidlack JM. Redefining the structure-activity relationships of 2,6-methano-3- benzazocines. 4. Opioid receptor binding properties of 8-[n-(4′-phenyl)- phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine Journal of Medicinal Chemistry. 49: 5635-5639. PMID 16942039 DOI: 10.1021/Jm060278N | 0.708 | |||
2006 | Parkhill AL, Bidlack JM. Reduction of lipopolysaccharide-induced interleukin-6 production by the kappa opioid U50,488 in a mouse monocyte-like cell line. International Immunopharmacology. 6: 1013-9. PMID 16644488 DOI: 10.1016/J.Intimp.2006.01.012 | 0.623 | |||
2004 | Bidlack JM, Parkhill AL. Assay of G protein-coupled receptor activation of G proteins in native cell membranes using [35S]GTP gamma S binding. Methods in Molecular Biology (Clifton, N.J.). 237: 135-43. PMID 14501046 DOI: 10.1385/1-59259-430-1:135 | 0.638 | |||
2002 | Parkhill AL, Bidlack JM. Several delta-opioid receptor ligands display no subtype selectivity to the human delta-opioid receptor. European Journal of Pharmacology. 451: 257-64. PMID 12242086 DOI: 10.1016/S0014-2999(02)02241-0 | 0.726 | |||
Show low-probability matches. |